Rx · Prescription onlyDissolved under the tongue
Semaglutide ODT
Weight loss, no needle.
Your plan
$219/mo, $1,314 billed once for 6 months/mo
$1,314 billed once for 6 months · unused months refunded on a medical stop
No membership fee · this is the full price · free shipping · monthly supply
- Medication, clinician care and dose adjustments, all in one price.
- ~30-day supply. Your clinician sets your exact dose, so yours may vary; your refill arrives as you finish the last one.
A licensed clinician on our care team reviews every request and prescribes only when it's clinically appropriate.
FDA status: Compounded medication, not FDA-approved. Its active ingredient, semaglutide, is also in the FDA-approved drugs Ozempic and Wegovy; this compounded version is not one of them.
What it's for
Who it's for
People who want semaglutide but will not use a needle.
How it's different
It dissolves under the tongue every day instead of one weekly injection, and far less reaches the blood than by injection.
How it works
Semaglutide ODT is a compounded tablet designed to dissolve under the tongue. It mimics the weekly GLP-1 injection but is taken by mouth. Absorption through the oral mucosa is lower and more variable than injected semaglutide; bioavailability data in humans are limited.
How to use it and what arrives
1 bottle · lasts 1 month
Your clinician sets your dose: 2–12 mg · same price at every dose
- How
- Dissolved under the tongue
- How often
- Once a day
Good to know
Take it on an empty stomach and wait 30 minutes before eating or drinking. Skipping that wait is the usual reason it underperforms.
What the research shows
Semaglutide is a GLP-1 receptor agonist. Its evidence comes from large randomized trials in adults with obesity, nearly all with the injected 2.4 mg weekly dose.
Weight
about 15%
STEP 1: 1,961 adults with obesity or overweight and no diabetes, 68 weeks of weekly injections plus lifestyle advice. Mean weight change was -14.9% with semaglutide and -2.4% with placebo.
STEP 1, NEJM 2021Two years
about 15%
STEP 5: 304 adults, 104 weeks of weekly 2.4 mg injections with behavioral support. Mean change was -15.2% with semaglutide and -2.6% with placebo.
STEP 5, Nature Medicine 2022Heart events
20% fewer events
SELECT: 17,604 adults aged 45 and older with overweight or obesity and existing heart disease but no diabetes, followed about 40 months. Major cardiovascular events were 6.5% on 2.4 mg weekly and 8.0% on placebo (hazard ratio 0.80).
SELECT, NEJM 2023
Trial results are for the injected 2.4 mg weekly product at the dose studied. They are averages, not predictions for one person. Compounded versions were not studied in these trials, and no trial has tested the sublingual (dissolve-under-the-tongue) form. The oral trial OASIS 4 (NEJM 2025, doi 10.1056/NEJMoa2500969) tested a 25 mg tablet swallowed, not a sublingual one.
What this does not say
- The trials ran 68 to 104 weeks. They do not show what happens over the long term after treatment is stopped.
- Nausea, diarrhea and vomiting were the most common side effects. In SELECT, 16.6% of people on semaglutide stopped the trial drug for adverse events, against 8.2% on placebo.
- SELECT and STEP trials were funded by the manufacturer; the figures are for brand-name semaglutide in trial conditions.
Sources
- Oral semaglutide 2.4 mg once daily with permeation enhancers: a phase 2b trial for weight loss. NEJM, 2019 (Buckley ST et al.)
- Semaglutide injection (Ozempic) mechanism and GLP-1 receptor agonism. Lancet, 2021 (Wilding JPH et al.)
Safety
FDA status: Compounded medication, not FDA-approved. Its active ingredient, semaglutide, is also in the FDA-approved drugs Ozempic and Wegovy; this compounded version is not one of them.
Side effects and precautions
- Oral semaglutide and tirzepatide are experimental formulations with limited human data.
- Common effects include nausea, diarrhea, constipation, and reduced appetite, often in the first weeks as absorption settles.
- Absorption is variable; blood levels may be unpredictable.
- Not for pregnancy or breastfeeding, or with a history of pancreatitis.
Get care right away
- Stop and seek care for severe abdominal pain, signs of pancreatitis, allergic reactions, or vision changes if diabetic.
When it isn't prescribed
- Do not use if you or a family member has had medullary thyroid carcinoma or MEN 2.
Tell your clinician about all medications, diabetes drugs, and any history of kidney or pancreatic disease.
Questions
How does oral semaglutide compare to the injection?
Injected semaglutide has decades of use and higher, more reliable blood levels. Sublingual semaglutide is newer; absorption is unpredictable. Your clinician may start at a higher dose to account for variable absorption and adjusts based on how you feel.
Why oral instead of injection?
Oral forms avoid needles. Be aware: absorption is unpredictable and lower than injections, so effects are less reliable. Your clinician will adjust your dose frequently as you respond.
What if absorption is poor?
If you see minimal effect after 4–6 weeks at a good dose, your clinician may increase the dose, try a different formulation, or recommend switching to injected GLP-1 for better reliability.
How often will I need adjustments?
Frequently at first, every 1–2 weeks in the first month, to find your effective dose. Once stable, check-ins may space out to monthly or every 2 months.
Can I switch between oral and injection?
Yes. If oral doesn't work well or you need more predictable results, your clinician can switch you to injected semaglutide or tirzepatide.
Ready to start with Semaglutide ODT?
$219/mo · $1,314 billed once for 6 months
- Free shipping on every order
- No membership fee
- Same price at every dose
- HSA and FSA accepted
More options in this area
Semaglutide + Glycine
Medical weight management
From $99 · 4-week supply
6 strengths · 250 mcg – 2.5 mg
